TERT and cancer: We have previously characterized multiple cancers with a comprehensive molecular profiling approach that uses various molecular techniques for the identification of potentially targetable biomarkers.9–13 Our initial case of metastatic LCT showed an LDLR:TERT gene fusion upon routine genetic profiling for the detection of therapeutic targets.